semaglutide progress 🌸 Spring is the season for fresh starts and your health goals deserve one too. If you've been feeling stuck or frustrated with your weight loss journey, remember: sustainable doesn't have ✨ Progress isn't just about

Schmajuk G, Miao Y, Yazdany J, Boscardin WJ, Daikh DI, Steinman MA

SPONSORED CONTENT July 01, 2026 2 min read Save Patients with recalcitrant hidradenitis suppurativa may respond to off-label golimumab More than half of patients with treatment-resistant hidradenitis suppurativa achieved a 55% improvement in their disease after initiating golimumab, a tumor necrosis factor inhibitor, according to a study published in JAMA Dermatology

Many users report decreased joint discomfort and reduced stiffness during demanding training periods

The injection technique is essentially the same for both

Courties, G

Early research suggested GIP receptor signalling might be impaired in type 2 diabetes